View Post

Lung cancer tumor growth halved with new approach

In In The News by Barbara Jacoby

By: Maria Cohut From: medicalnewstoday.com New research from Sweden has taken strides toward finding a cure for lung cancer. It focused on noncoding molecules that have been puzzling scientists for a long time. According to the National Cancer Institute (NCI), lung cancer caused around 25.9 percent of all cancer-related deaths last year and accounted for 13.2 percent of all new …

View Post

Have scientists found an anti-cancer vaccine?

In In The News by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com Researchers from Stanford University used stem cells to create a vaccine that has proven effective against breast, lung, and skin cancer in mice. To produce the vaccine, the scientists turned to induced pluripotent stem cells (iPSCs), or stem cells that are generated from adult cells. Over a decade ago, Japanese-based scientists showed for the first …

View Post

New biomarkers predict outcome of cancer immunotherapy

In In The News by Barbara Jacoby

Source: University of Zurich From: sciencedaily.com Nowadays, melanoma and lung cancer can be combatted effectively through immunotherapy, which makes targeted use of the immune system’s normal function of regularly examining the body’s tissue for pathogens and damages. Specific inhibitors are used to activate immune cells in a way that makes them identify cancer cells as foreign bodies and eliminate them. …

View Post

Astra’s Immune Drug First to Check Mid-Stage Lung Cancer Growth

In In The News by Barbara Jacoby

By: John Lauerman and Naomi Kresge From: bloomberg.com AstraZeneca Plc’s Imfinzi stalled the progress of mid-stage lung cancers in a trial, offering patients a potential new therapy for the deadly condition and boosting the U.K. company’s prospects in the race to develop breakthrough treatments. Patients who received Imfinzi after radiation and chemotherapy saw growth of their tumors pause about three times as …

View Post

New chemoprevention trial hopes to stop dangerous lesions from progressing to cancer

In In The News by Barbara Jacoby

From: news-medical.net New treatments have extended the lives of many lung cancer patients. However, even better than treating lung cancer would be preventing it from developing in the first place. An ongoing clinical trial by University of Colorado Cancer Center investigators working at Denver Veterans Administration Hospital and in association with the National Cancer Institute Division of Chemoprevention is evaluating …

View Post

A Cuban vaccine might some day turn lung cancer into a chronic disease

In In The News by Barbara Jacoby

By: Mimi Whitefield From: miamiherald.com The first patients in a clinical trial at Roswell Park Cancer Institute have begun receiving monthly doses of CIMAvax-EGF, a Cuban lung cancer vaccine that U.S. researchers say shows promise in preventing the recurrence of lung cancer — the leading cause of cancer deaths in the United States. The Roswell trial, which was authorized by …

View Post

Doctors Excited By Results Of New Immunotherapy Cancer Treatment

In In The News by Barbara Jacoby

By: Dr. Maria Simbra From: pittsburgh.cbslocal.com No chemotherapy, No radiation. There’s a new way to treat cancer that doesn’t involve either. It’s working for patients and even doctors are excited about it. Joe Milcarek had no symptoms of lung cancer. Doctors discovered it on scans he had as part of participation in a lung study. “They found a tumor about …

View Post

New Spanish-language videos and brochures provide cancer patients with overview of radiation therapy

In In The News by Barbara Jacoby

From: PR Newswire Cancer patients who speak Spanish have new tools to help them understand treatment options for their disease. The American Society for Radiation Oncology (ASTRO) today released a series of Spanish-language patient videos on radiation therapy for cancer, including breast, prostate, lung, brain and other common cancer types. The videos complement a set of Spanish-language brochures on radiation …

View Post

‘Exciting’ blood test spots cancer a year early

In In The News by Barbara Jacoby

By: James Gallagher From: bbc.com Doctors have spotted cancer coming back up to a year before normal scans in an “exciting” discovery. The UK team was able to scour the blood for signs of cancer while it was just a tiny cluster of cells invisible to X-ray or CT scans. It should allow doctors to hit the tumour earlier and …

View Post

Trial Of Immune Drug In Breast Cancer Points To Need For Biomarkers

In In The News by Barbara Jacoby

By: Elaine Schattner From: forbes.com At first glance, results with a powerful immune agent in breast cancer appear negative. In an early-phase clinical trial, only 10% of patients with metastatic disease responded to atezolizumab (Tecentriq). Yet for those few women who did respond, the benefit was dramatic. Among 112 women with evaluable, advanced disease, 11 have experienced durable responses lasting …